In your stateVermont
In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.
Economic Impact In Your State: Vermont
$1.1B
Total output supported by biophamaceutical sector
$494,166
Total output supported by biophamaceutical sector
4,690
Total Jobs
1,157
Direct Jobs
Clinical Trials in Your State: Vermont
91
TOTAL CLINICAL TRIALS
$12.2 million
INVESTED IN CLINICAL TRIALS
1106
TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS
$30 million
INVESTED IN CLINICAL TRIALS
Programs and Initiatives in Your State: Vermont
State programs and initiatives to promote biopharmaceutical industry development
- ACCELERATING INNOVATION, COMMERCIALIZATION & ENTREPRENEURIAL DEVELOPMENT
ECONOMIC INNOVATION INCENTIVES
VENTURE FINANCING